Firebrick Pharma Ltd (fre) Logo

Firebrick Pharma Ltd (FRE)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News
Announcements

FRE ASX Chart

Snapshot

Firebrick Pharma Limited (FRE) is developing and commercialising novel formulations and uses of povidone iodine (PVP-I). The Company has developed and manufactured Nasodine Nasal Spray (0.5% PVP-I), which so far has been introduced into the United States, Singapore, and Fiji & South Pacific. The Company is pursuing approval in other markets, including the Philippines.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2026 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -55.47%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,971 of 2,337
Sector Rank 184 of 241

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies RGT / EPN / NGS
EPS -$0.011
DPS $0.00
Book Value Per Share $0.007

Broker Consensus

FRE is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Melbourne VIC 3000
Website firebrickpharma.com
Registry Automic Group
Auditor BDO Audit Pty Ltd
Date Listed 28 Jan 2022

Upcoming Calendar (Forecasted)

Date Event
28/08/2026 Report (Prelim)
28/08/2026 Report (Annual)
23/02/2027 Report (Interim)

Former Company Names

  • Firebrick Pharma Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

FRE directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
20/05/26 Peter Molloy Buy +245,000 $0.04 $9,856 On-market trade
20/05/26 Stephen Goodall Buy +110,000 $0.046 $5,060 On-market trade
10/10/24 Stephen Goodall Buy +181,818 $0.055 $10,000 Participation in share purchase plan
10/10/24 Peter Molloy Buy +454,545 $0.055 $25,000 Participation in share purchase plan
27/06/24 Peter Molloy Buy +500,000 $0.057 $28,437 On-market trade
20/06/23 Stephen Goodall Issued 530,000 $0.15 $79,500 Placement
20/06/23 Stephen Goodall Transfer 30,326,472 $0.155 $4,700,603 Off-market transfer
20/06/23 Stephen Goodall Transfer 30,326,472 $0.155 $4,700,603 Off-market transfer
20/06/23 Peter Molloy Transfer 30,326,472 $0.155 $4,700,603 Off-market transfer
20/06/23 Peter Molloy Transfer 30,326,472 $0.155 $4,700,603 Off-market transfer
20/06/23 Peter Molloy Issued 530,000 $0.15 $79,500 Placement
24/11/22 Phyllis Gardner Issued 100,000 $0.173 $17,325 Director remuneration
24/11/22 Richard Treagus Issued 100,000 $0.173 $17,325 Director remuneration

Director Interests

The current holdings of FRE directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Stephen Goodall 20/05/2026 0 31,148,290 N/A N/A
Peter Molloy 20/05/2026 0 32,056,017 N/A N/A
Al Moghaddam 01/03/2026 N/A N/A 1,000,000 N/A
Rick Legleiter 01/08/2025 N/A N/A 1,000,000 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on Aug 3, 2025.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Aquarico Pty Ltd <P & C Molloy Family A/C> 30,326,472 13.34%
Biotech Design Pty Ltd 30,326,472 13.34%
GZ Family Holdings Pty Ltd <GZ Family A/C> 22,347,112 9.83%
Pharma Nutria Na Inc 11,578,947 5.09%
Mr Timothy Don Kennedy 3,464,298 1.52%
Mr Ian Douglas Robertson 3,365,731 1.48%
BNP Paribas Noms Pty Ltd 3,222,017 1.42%
Ms Helen Frances Morgan 2,744,507 1.21%
Mr Ivan Kaufman 2,550,000 1.12%
Dr Jonathan Bryden Dalitz & Mrs Michelle Anne Dalitz <Dalitz Super Fund A/C> 2,508,982 1.10%
Kashflow 18 LLC 2,103,713 0.93%
Zero Nominees Pty Ltd 1,895,000 0.83%
Hannes Investments Pty Ltd <Double D Investment A/C> 1,870,000 0.82%
Mr Peter Friedland 1,800,000 0.79%
Mr Simon Tucker 1,800,000 0.79%
The Shed Man Pty Ltd 1,750,000 0.77%
Uujaypee Pty Ltd <Pickering S/F A/C> 1,725,454 0.76%
Mrs Jill Robin Margo 1,564,918 0.69%
GB & JK Porter Pty Ltd <GB & JK Porter S/F A/C> 1,500,000 0.66%
Mrs Christine Louise Molloy 1,484,545 0.65%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 676 1,619 556 822 205 3,878

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Stephen Francis Goodall 17/04/2026 31,038,290 10.90
Peter Laurence Molloy 17/04/2026 31,811,017 11.17
Pharma Nutria N.A Inc 16/10/2025 12,778,947 5.08
GZ Family Holdings Pty Ltd 17/04/2026 24,255,058 8.51

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
16-10-25 Pharma Nutria N.A Inc 12,778,947 -- 5.08

Shareholders Selling

12 month transaction history compiled from ASX announcements.

Date Name Sold Previous % New %
29-08-25 GZ Family Holdings Pty Ltd 344,942 12.60 9.71
29-08-25 Pharma Nutria N.A Inc 11,578,947 5.22 --

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2025 $0.062 30 June
2024 $0.056 28 June
2023 $0.155 30 June
2022 $0.265 30 June
FRE Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.